vascular surgery Articles
-
Some results of studying laser micromachining at medical stents manufacturing
Cardio-vascular diseases are the number one killer in the world. As an alternative to common treatment methods the installation of specific-purpose stents into the damaged blood vessel could be used in order to minimise fatal outcomes. Existing technologies of stent manufacturing provide quite good results but are very expensive at the moment. The given paper deals with the design of stents for ...
-
Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access
Objective: Patients with end stage renal failure who require haemodialysis suffer morbidity and mortality due to vascular access. Bioengineered human acellular vessels (HAVs) may provide a haemodialysis access option with fewer complications than other grafts. In a prospective phase II trial from 2012 to 2014 (NCT01744418), HAVs were implanted into 40 haemodialysis patients at three sites in ...
-
Clinical implementation of the Humacyte human acellular vessel: Implications for military and civilian trauma care
ABSTRACT: The incidence of wartime vascular injury has increased and is a leading cause of mortality and morbidity. While ligation remains an option, current resuscitation and damage control techniques have resulted in vascular repair being pursued in more than half of wartime injuries. Options for vascular reconstruction are currently limited to autologous vein or synthetic conduits, choices ...
-
Cost-Effectiveness of Percutaneous Deep Vein Arterialization for Patients with No-Option Chronic Limb-Threatening Ischemia: an Exploratory Analysis Based on the PROMISE I Study
Abstract Background. As the most advanced stage of peripheral arterial disease (PAD), chronic limb-threatening ischemia (CLTI) is associated with a high risk of lower-limb loss and mortality. Percutaneous deep vein arterialization (pDVA) is a promising new treatment alternative for CLTI patients who cannot be treated with conventional revascularization techniques. Our study objective was to ...
-
Amplifi Vein Dilation System: A novel device under development designed to prepare veins for AVF creation
The Amplifi Vein Dilation System (Artio Medical) is is an innovative device designed to dilate arm veins in preparation for AVF surgery using rapid, non-pulsatile venous blood flow. Surendra Shenoy, M.D. (a vascular surgeon with specialist interest in vascular access and transplantation at Washington University School of Medicine, St Louis, Missouri, USA) describes the system as one of the most ...
-
HBOT for Complementary Therapy
If you’re considering HBOT, it’s important to understand the benefits and risks this therapy entails. The treatment should be discussed with a certified healthcare professional to develop a plan of action based on scientific evidence and tailored to your exact condition. Hyperbaric oxygen therapy can be used as complementary therapy to address several medical problems. The theory ...
-
The tiny grabber that plucks blood clots out of a vein (The Mail on Sunday)
Thousands of patients suffering from deep vein thrombosis (DVT) are set to benefit from a lifesaving procedure using a new blood clot grabbing device pioneered by NHS specialists. The treatment involves inserting a stent, a tiny, ball- shaped wire cage into a blocked vein. Once in position, the collapsible cage is expanded and ‘ catches’ the clot. When the device is pulled out, the ...
-
Cleveland Clinic: First Case Completed in Feasibility Study of Non-Radiation-Based EVAR Navigation Platform
MOTION study will quantify new technology’s impact on radiation exposure In December, Cleveland Clinic vascular surgeons successfully completed the first surgical case in the MOTION clinical trial of a new non-radiation-based surgical navigation platform for endovascular aortic interventions. The trial is a feasibility study of the Intra-Operative Positioning System (IOPS™) from ...
-
The Evolving Role of Percutaneous Deep Venous Arterialization
The increasing incidence of peripheral artery disease (PAD) is occurring globally as populations age and rates of diabetes, obesity, and renal disease increase.1-3 Although most of these patients have no symptoms, when the disease progresses to its most advanced form, chronic limb-threatening ischemia (CLTI), there is a significant risk for limb loss. Despite the fact that our revascularization ...
-
LimFlow Percutaneous Deep Venous Arterialization
What interested you in LimFlow, and how did you get involved in the PROMISE I trial? Dr. Clair: Practicing vascular surgery, where a number of patients are evaluated for chronic limb-threatening ischemia (CLTI), you are guaranteed to have patients who are not candidates for percutaneous or surgical revascularization. These patients often have arterial systems open or identifiable to the ankle, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you